ADDF – Harrington Scholar Award – Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: Wednesday 6th, September 2023
External Deadline: Monday 11th, September 2023
Description
Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the US, UK and Canada.
Applications for this opportunity are by invitation only. To be eligible for an invitation an LOI must be submitted
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute provide funding and drug development support of research efforts that aim to treat or prevent Alzheimer’s disease, related dementias and cognitive-decline associated with aging. Each year up to two ADDF-Harrington Scholars are chosen. The award includes:
- Two-year grant
- Funding up to $600,000
- Drug development expertise and project management support
- A personalized team of drug developers and project manager for each award recipient
- Expert business, commercialization and clinical development advice
- Regulatory assistance
- Intellectual property (IP) review and advice
- Assistance identifying and securing additional financial support based on project needs
- Timelines:
- Call Opens for Letters of Intent (LOI) April 3, 2023
- LOI Submission Deadline May 29, 2023
- Full Application Deadline for those Invited September 11, 2023
- Announce 2023 ADDF-Harrington Scholars March 2024
Visit the Harrington Discovery Insitute to learn more about the ADDF-Harrington Scholar program.
Questions? Email grants@alzdiscovery.org or Questions@HarringtonDiscovery.org.
Scientific inquiries? Email Meriel Owen, PhD, ADDF at mowen@alzdiscovery.org.